7Z50 image
Entry Detail
PDB ID:
7Z50
Keywords:
Title:
Structure of the highly diabetogenic 4.1-T cell receptor targeting a hybrid insulin peptide bound to I-Ag7.
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2022-03-06
Release Date:
2022-07-20
Method Details:
Experimental Method:
Resolution:
2.65 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:H-2 class II histocompatibility antigen, A-D alpha chain
Mutations:I91C
Chain IDs:A, C
Chain Length:202
Number of Molecules:2
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:H2-Ab1 protein
Chain IDs:B, D
Chain Length:230
Number of Molecules:2
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:4.1 TCR beta chain
Chain IDs:E, F
Chain Length:242
Number of Molecules:2
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:4.1 TCR alpha chain
Chain IDs:G, H
Chain Length:207
Number of Molecules:2
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:Hybrid insulin peptide
Chain IDs:I (auth: T), J (auth: W)
Chain Length:15
Number of Molecules:2
Biological Source:Mus musculus
Primary Citation
Structural plasticity in I-A g7 links autoreactivity to hybrid insulin peptides in type I diabetes.
Front Immunol 13 924311 924311 (2022)
PMID: 35967292 DOI: 10.3389/fimmu.2022.924311

Abstact

We recently provided evidence for promiscuous recognition of several different hybrid insulin peptides (HIPs) by the highly diabetogenic, I-Ag7-restricted 4.1-T cell receptor (TCR). To understand the structural determinants of this phenomenon, we solved the structure of an agonistic HIP/I-Ag7 complex, both in isolation as well as bound to the 4.1-TCR. We find that HIP promiscuity of the 4.1-TCR is dictated, on the one hand, by an amino acid sequence pattern that ensures I-Ag7 binding and, on the other hand, by the presence of three acidic residues at positions P5, P7 and P8 that favor an optimal engagement by the 4.1-TCR's complementary determining regions. Surprisingly, comparison of the TCR-bound and unbound HIP/I-Ag7 structures reveals that 4.1-TCR binding triggers several novel and unique structural motions in both the I-Ag7 molecule and the peptide that are essential for docking. This observation indicates that the type 1 diabetes-associated I-Ag7 molecule is structurally malleable and that this plasticity allows the recognition of multiple peptides by individual TCRs that would otherwise be unable to do so.

Legend

Protein

Chemical

Disease

Primary Citation of related structures